병원용 가운 시장 : 시장 점유율 분석, 업계 동향 및 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the hospital gowns market size is expected to grow from USD 3.83 billion in 2025 to USD 4.11 billion in 2026 and is forecast to reach USD 5.89 billion by 2031 at 7.43% CAGR over 2026-2031.

This report is Segmented by Usability (Disposable, Reusable), Type (Surgical, Non-Surgical, Patient Gowns), Risk Type (Minimal, Low, Moderate, High Risk), End User (Hospitals and Clinics, Long-Term Care, Ambulatory Surgical Centers, Home Healthcare), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America). The Market Forecasts are Provided in Terms of Value (USD).

Global Hospital Gowns Market Trends and Insights

Infection Control Mandates And HAI Prevention

Healthcare associated infections continue to create a firm demand floor for the hospital gowns market because prevention protocols require regular gown use in acute care, long term care, and other patient contact settings. WHO reported that healthcare associated infections add 25 million extra hospital days each year in Europe and impose EUR 13-24 billion (USD 15.1 to 27.9 billion) in annual costs, which keeps infection prevention spending difficult to defer. OECD also found that infection prevention and control measures, including appropriate gown use, can reduce infections by up to 70% and return USD 24.6 for every USD 1 invested across OECD and EU and EEA countries. The burden is even higher in lower income settings, where WHO noted much greater infection incidence, and that pushes large public systems to formalize procurement of protective apparel rather than treat it as a variable line item. In the United States, CDC guidance on Enhanced Barrier Precautions is extending routine gown use into nursing home activities that involve close contact, which broadens the addressable base for the hospital gowns market beyond hospitals alone.

Surgical Volume Growth And Procedural Throughput Requirements

Procedure growth continues to support the hospital gowns market because surgical case recovery has moved beyond backlog clearing and into a broader expansion of outpatient and minimally invasive care pathways. The Lancet projected global surgical volumes at no less than 160 million operations annually, which implies durable consumption of surgical gowns across hospital and ambulatory settings. CMS added 289 procedures to the ASC Covered Procedures List for 2026, which keeps moving more cases into ambulatory settings where throughput matters and disposable configurations remain common. That site of care shift matters because high acuity procedures done in ASCs often use tightly standardized packs and lean room turnover protocols, which increases the operational value of dependable gown supply. As a result, procedure growth is not only lifting unit demand in the hospital gowns market, it is also changing the mix toward products that can support faster turnover, predictable compliance, and easier inventory control.

Premium Product Cost Pressure In Budget-Constrained Facilities

Cost pressure remains a real brake on the hospital gowns market because higher barrier garments raise procurement costs for facilities that already face tight operating budgets. The 2025 international study covering 5,230 perioperative professionals across 134 countries found that financial constraints were the most frequently cited barrier to improving gown quality, identified by 19.9% of respondents. The same study showed that infrastructure limits and cost pressures often appear together, which means facilities do not move through adoption stages in a simple sequence. Smaller ASCs, long term care centers, and public hospitals also lack the purchasing leverage available to large integrated networks, so per unit costs can stay structurally higher for them. This keeps part of the hospital gowns market anchored to basic product tiers, even where clinical teams would prefer better comfort, breathability, or barrier performance.

Other drivers and restraints analyzed in the detailed report include:

1. Rising Preference For Disposable Gowns In High-Turnover Care Settings
2. Sustainability-Led Reusable Gown Procurement In Mature Health Systems
3. Regulatory And Barrier-Performance Compliance Complexity

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Disposable Gowns held 56.31% of the hospital gowns market share in 2025, which reflected their deep use in acute care hospitals, ASCs, and emergency settings where single patient use remains central to workflow discipline. Their position in the hospital gowns market is supported by fast turnover, simple logistics, and a lower need for internal textile management. Facilities that face unpredictable caseloads or limited reprocessing infrastructure still rely on disposables because they remove the risk of laundry bottlenecks and reduce coordination across departments. This makes disposable volume resilient even as the broader hospital gowns market shifts toward more selective product and service combinations.

Reusable Gowns are forecast to grow at a 10.38% CAGR during 2026-2031, making them the faster moving usability segment as sustainability goals and life cycle cost reviews gain more weight in procurement. The 2025 global perioperative study found that sterilization related limits remain a core barrier, so reusable adoption depends less on clinical acceptance and more on service readiness. In practice, the hospital gowns industry is moving toward coexistence rather than replacement, with reusable programs strongest in planned surgical environments and disposable demand staying firm in emergency, trauma, and outpatient channels. Hybrid procurement models fit this reality well because they let systems use reusable textiles for scheduled operating room volume and keep disposable stock for surge periods and high turnover care. Suppliers that can serve both models should be better placed in the hospital gowns market because buyers increasingly want flexibility instead of a single format commitment.

Surgical Gowns accounted for 45.24% share of the hospital gowns market size in 2025, which reflected their mandatory role in operative care and their higher average value under stricter barrier requirements. Their lead in the hospital gowns market is tied to every procedure that demands controlled sterile conditions, including cardiothoracic, orthopedic, laparoscopic, and other fluid exposure settings. Non surgical gowns remain an important institutional category because they support isolation, contact precautions, chemotherapy handling, and other procedural needs shaped by infection control guidance. This keeps type level demand broad based, with surgical, non surgical, and patient use categories responding to different care pathways rather than one common demand pattern.

Patient Gowns are projected to grow at a 10.52% CAGR during 2026-2031, which is a faster pace than the overall hospital gowns market because outpatient care and home based services are expanding. More ambulatory centers and independent clinics are now buying directly instead of drawing from hospital led channels, which is widening the purchasing base for this category. Design upgrades are also giving patient gowns more strategic value, especially where comfort, dignity, and better handling support patient experience goals. In procedural settings, some patient facing garments are also moving closer to standardized fluid protection expectations when exposure risk is present. The result is that patient gowns no longer sit only at the low end of the hospital gowns market, because service model changes are making them a more active source of recurring volume.

Complete Report Scope:

• By Usability
  • Disposable Gowns
  • Reusable Gowns
• By Type
  • Surgical Gowns
  • Non-Surgical Gowns
  • Patient Gowns
• By Risk Type
  • Minimal Risk Gowns
  • Low Risk Gowns
  • Moderate Risk Gowns
  • High Risk Gowns
• By End User
  • Hospitals and Clinics
  • Long-Term Care Facilities
  • Ambulatory Surgical Centers
  • Home Healthcare
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America accounted for 38.52% of the hospital gowns market share in 2025, which made it the largest regional contributor on the back of a dense accredited provider base, clear AAMI alignment, and strong purchasing scale. The United States remains the central revenue engine in the hospital gowns market because its hospitals, ASCs, and group purchasing organizations favor suppliers with dependable logistics and strong compliance records. Canada adds a different layer, with centralized procurement and growing interest in reusable gown programs that fit broader health system sustainability goals. Mexico continues to develop as a growth market as public and private providers expand structured procurement for surgical and infection prevention products. Regulatory scrutiny also intensified after the August 2025 DOJ settlement involving adulterated MicroCool surgical gowns, which raised the importance of testing credibility and supplier documentation across North American sourcing decisions.

Europe remains a strategically distinct region in the hospital gowns market because sustainability targets are changing how buyers compare single use and reusable options. Western European systems are moving faster on reusable operating room textiles, and Barts Health NHS Trust provided a visible example in 2025 with a large reusable gown contract tied to waste reduction goals. The regional backdrop is still shaped by a high infection burden, with OECD reporting around 4.3 million healthcare associated infection episodes each year in EU acute care hospitals, which sustains the baseline need for gowns across member states. This leaves Europe with a dual demand structure in the hospital gowns market, where infection control keeps volumes steady while sustainability policy changes the preferred textile model.

Asia-Pacific is forecast to expand at a 9.55% CAGR during 2026-2031, making it the fastest growing regional block in the hospital gowns market. China held the largest regional share in 2025 as hospital expansion, procurement rationalization, and export capability strengthened the role of validated gown categories. India is also adding scale through government backed hospital expansion and a growing private system that demands higher performance products. The Middle East and Africa shows a split pattern, with GCC systems moving toward international standards and local production initiatives such as Molnlycke's Saudi joint venture, while much of sub Saharan Africa remains limited by budget and infrastructure constraints. South America is being supported by structured public and private procurement in Brazil and a gradual normalization of institutional purchasing in Argentina.

1. Ahlstrom Oyj
2. AmeriPride Services, Inc.
3. Ansell
4. Atlas Infiniti Limited
5. B. Braun
6. Bellcross Industries Pvt. Ltd.
7. Cardinal Health
8. Dynarex
9. Lohmann & Rauscher GmbH and Co. KG
10. Medline Industries
11. Molnlycke Health Care
12. Owens & Minor, Inc.
13. Hartmann Group
14. Priontex Ltd.
15. Sara Healthcare Pvt. Ltd.
16. Solventum Corporation
17. Standard Textile Co., Inc.
18. TIDI Products, LLC

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Infection Control Mandates and Hospital-Acquired Infection Prevention
  • 4.2.2 Surgical Volume Growth and Procedural Throughput Requirements
  • 4.2.3 Rising Preference for Disposable Gowns in High-Turnover Care Settings
  • 4.2.4 Sustainability Led Reusable Gown Procurement in Mature Health Systems
  • 4.2.5 Reusable Gown Laundering Validation and Closed-Loop Service Models
  • 4.2.6 Gown Performance Verification, Traceability, and Procurement Digitization
• 4.3 Market Restraints
  • 4.3.1 Premium Product Cost Pressure in Budget-Constrained Facilities
  • 4.3.2 Regulatory and Barrier-Performance Compliance Complexity
  • 4.3.3 Supply Chain Dependence on Nonwoven and Meltblown Inputs
  • 4.3.4 Operational Readiness Gaps for Reusable Gown Adoption
• 4.4 Supply Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces Analysis
  • 4.7.1 Threat of New Entrants
  • 4.7.2 Bargaining Power of Suppliers
  • 4.7.3 Bargaining Power of Buyers
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Competitive Rivalry

5 Market Size & Growth Forecasts (Value, USD)

• 5.1 By Usability
  • 5.1.1 Disposable Gowns
  • 5.1.2 Reusable Gowns
• 5.2 By Type
  • 5.2.1 Surgical Gowns
  • 5.2.2 Non-Surgical Gowns
  • 5.2.3 Patient Gowns
• 5.3 By Risk Type
  • 5.3.1 Minimal Risk Gowns
  • 5.3.2 Low Risk Gowns
  • 5.3.3 Moderate Risk Gowns
  • 5.3.4 High Risk Gowns
• 5.4 By End User
  • 5.4.1 Hospitals and Clinics
  • 5.4.2 Long-Term Care Facilities
  • 5.4.3 Ambulatory Surgical Centers
  • 5.4.4 Home Healthcare
• 5.5 By Geography
  • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
  • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
  • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 Japan
    • 5.5.3.3 India
    • 5.5.3.4 Australia
    • 5.5.3.5 South Korea
    • 5.5.3.6 Rest of Asia-Pacific
  • 5.5.4 Middle East and Africa
    • 5.5.4.1 GCC
    • 5.5.4.2 South Africa
    • 5.5.4.3 Rest of Middle East and Africa
  • 5.5.5 South America
    • 5.5.5.1 Brazil
    • 5.5.5.2 Argentina
    • 5.5.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global Level Overview, Market Level Overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share, Products and Services, Recent Developments)
  • 6.3.1 Ahlstrom Oyj
  • 6.3.2 AmeriPride Services, Inc.
  • 6.3.3 Ansell Limited
  • 6.3.4 Atlas Infiniti Limited
  • 6.3.5 B. Braun Melsungen AG
  • 6.3.6 Bellcross Industries Pvt. Ltd.
  • 6.3.7 Cardinal Health, Inc.
  • 6.3.8 Dynarex Corporation
  • 6.3.9 Lohmann & Rauscher GmbH and Co. KG
  • 6.3.10 Medline Industries, LP
  • 6.3.11 Molnlycke Health Care AB
  • 6.3.12 Owens & Minor, Inc.
  • 6.3.13 Paul Hartmann AG
  • 6.3.14 Priontex Ltd.
  • 6.3.15 Sara Healthcare Pvt. Ltd.
  • 6.3.16 Solventum Corporation
  • 6.3.17 Standard Textile Co., Inc.
  • 6.3.18 TIDI Products, LLC

7 Market Opportunities & Future Outlook

• 7.1 White-space & unmet-need assessment